Toggle navigation
CERSI
Excipients
Home
Molecular
Oral
Unresolved
Rarely Used
Products
APIs
Semaglutide
Active Ingredient
External Links
Google
,
Wikipedia
,
PubMed
,
DailyMed
,
Raw OpenFDA
,
ECHA
,
ToxNet
,
JECFA
,
FAO
,
21 CFR
All Co-Formulated Excipients (0 Total)
None
Available Products (3 Total)
Product name
Manufacturer
Route
Approved Date
1.
Rybelsus
Novo Nordisk
Oral
2.
Ozempic
Remedyrepack Inc.
Subcutaneous
3.
Ozempic
Novo Nordisk
Subcutaneous
Comments
Please enable JavaScript to view the
comments powered by Disqus.